Cargando…

Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review

BACKGROUND: Transgender individuals receiving masculinising or feminising gender-affirming hormone therapy with testosterone or estradiol respectively, are at increased risk of adverse cardiovascular outcomes, including myocardial infarction and stroke. This may be related to the effects of testoste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spanos, Cassandra, Bretherton, Ingrid, Zajac, Jeffrey D, Cheung, Ada S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Systematic Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061235/ https://www.ncbi.nlm.nih.gov/pubmed/32180895 http://dx.doi.org/10.4239/wjd.v11.i3.66

Ejemplares similares

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study
por: Foster Skewis, Lucas, et al.
Publicado: (2021)

Insulin resistance in transgender individuals correlates with android fat mass
por: Bretherton, Ingrid, et al.
Publicado: (2021)

Gender-affirming hormone therapy induces specific DNA methylation changes in blood
por: Shepherd, Rebecca, et al.
Publicado: (2022)

Characterising body composition and bone health in transgender individuals receiving gender‐affirming hormone therapy
por: Ford, Ky, et al.
Publicado: (2022)

Gender Affirming Body Contouring and Physical Transformation in Transgender Individuals
por: Asokan, Arjun, et al.
Publicado: (2022)

Bone Microarchitecture in Transgender Adults: A Cross‐Sectional Study
por: Bretherton, Ingrid, et al.
Publicado: (2022)

Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review
por: Connelly, Paul J., et al.
Publicado: (2021)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Forensic alcohol calculations in transgender individuals undergoing gender‐affirming hormonal treatment
por: Maskell, Peter D., et al.
Publicado: (2022)

SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023)

Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study
por: Suppakitjanusant, Pichatorn, et al.
Publicado: (2020)

Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022)

Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment
por: Masumori, Naoya, et al.
Publicado: (2023)

Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy
por: Nolan, Brendan J., et al.
Publicado: (2020)

Cancer screening and management in the transgender population: Review of literature and special considerations for gender affirmation surgery
por: Panichella, Juliet C, et al.
Publicado: (2023)

Sexual Satisfaction After Gender Affirmation Surgery in Transgender Individuals
por: Jerome, Renard R, et al.
Publicado: (2022)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy
por: Yau, Mabel, et al.
Publicado: (2023)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
por: Connelly, Paul J., et al.
Publicado: (2019)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

Gender affirming hormone therapy dosing behaviors among transgender and nonbinary adults
por: Restar, Arjee, et al.
Publicado: (2022)

Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women
por: de Nie, Iris, et al.
Publicado: (2023)

Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy
por: Sánchez-Toscano, Esteban, et al.
Publicado: (2023)

The Health and Well-Being of Transgender Australians: A National Community Survey
por: Bretherton, Ingrid, et al.
Publicado: (2021)

A Review of Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults in South Korea
por: OH, Jeong-Won, et al.
Publicado: (2022)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

Sociodemographic and Clinical Characteristics of Transgender Adults in Australia
por: Cheung, Ada S., et al.
Publicado: (2018)

Impact Of Gender Affirming Treatment in Body Image and Quality of Life Among Transgenders
por: Vijay, B., et al.
Publicado: (2022)

An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy
por: Maheshwari, Arvind, et al.
Publicado: (2021)

The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand
por: Ittiphisit, Sakditat, et al.
Publicado: (2022)

Breast cancer in a transgender woman undergoing gender-affirming exogenous hormone therapy
por: Villalba, Michael D., et al.
Publicado: (2023)

OR31-04 Testosterone Therapy On Gender Dysphoria, Depression, And Suicidality In Transgender And Gender Diverse Individuals Seeking Masculinisation: A Randomised Controlled Trial
por: Nolan, Brendan J, et al.
Publicado: (2023)

Uncovering the effects of gender affirming hormone therapy on skeletal muscle and epigenetics: protocol for a prospective matched cohort study in transgender individuals (the GAME study)
por: Jones, Patrice R, et al.
Publicado: (2022)

Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults
por: Iwamoto, Sean J., et al.
Publicado: (2023)

Desire for genetically related children among transgender and gender-diverse patients seeking gender-affirming hormones
por: Kyweluk, Moira A., et al.
Publicado: (2023)

Integrated and Gender-Affirming Transgender Clinical Care and Research
por: Reisner, Sari L., et al.
Publicado: (2016)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

Factors Associated with Gender-Affirming Surgery and Age of Hormone Therapy Initiation Among Transgender Adults
por: Beckwith, Noor, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h0pgdclond975as04esrnivdq0